Vitamin E

Novartis Foundation Symposium

Volumn 282, Issue , 2007, Pages 77-87

  Stocker, Roland ^a,b,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; VITAMIN;

ALPHA TOCOPHEROL DEFICIENCY; DIET SUPPLEMENTATION; DOSE RESPONSE; EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; HEALTH STATUS; HUMAN; NUTRITIONAL REQUIREMENT; PHYSIOLOGY; REVIEW;

ANTIOXIDANTS; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EVIDENCE-BASED MEDICINE; HEALTH STATUS; HUMANS; NUTRITION POLICY; NUTRITIONAL REQUIREMENTS; VITAMIN E; VITAMIN E DEFICIENCY; VITAMINS;

EID: 35448957662     PISSN: 15282511     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (41)

1. Bieri JG, Farrell PM 1976 Vitamin E. Vitam Horm 34:31-75
2. Boaz M, Smetana S, Weinstein T et al 2000 Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 356:1213-1218
3. Brigelius-Flohé R, Traber MG 1999 Vitamin E: function and metabolism. FASEB J 13:1145-1155
4. Brown BG, Zhao XQ, Chait A et al 2001 Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 345:1583-1592
5. Burton GW, Ingold KU 1981 Autoxidation of biological molecules. 1. The antioxidant activity of vitamin E and related chain-breaking phenolic antioxidants in vitro. J Am Chem Soc 103:6472-6477
6. Burton GW, Ingold KU 1986 Vitamin E: Application of the principles of physical organic chemistry to the exploration of its structure and function. Acc Chem Res 19:194-201
7. Burton GW, Joyce A, Ingold KU 1982 First proof that vitamin E is major lipid-soluble, chain-breaking antioxidnat in human blood plasma. Lancet ii:327
8. Choy K, Beck K, Png FY et al 2005 Processes involved in the site-specific effect of probucol on atherosclerosis in apolipoprotein E gene knockout mice. Arterioscl Thromb Vasc Biol 25:1684-1690
9. Christiansen-Weber TA, Voland JR, Wu Y et al 2000 Functional loss of ABCA1 in mice causes severe placental malformation, aberrant lipid distribution, and kidney glomerulonephritis as well as high-density lipoprotein cholesterol deficiency. Am J Pathol 157:1017-1029
10. Evans HM, Bishop KS 1922 On the existence of a hitherto unrecognized dietary factor essential for reproduction. Science 56:650-651
11. Halliwell B, Gutteridge JMC 1999 Free radicals in biology and medicine. New York, Oxford University Press
12. Hanley DF, Miller ER 2005 An editorial update: annus horribilis for vitamin E. Ann Intern Med 143:143-145
13. Hodis HN, Mack WJ, LaBree L et al 2002 Alpha-tocopherol supplementation in healthy individuals reduces low- density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS). Circulation 106:1453-1459
14. Hosomi A, Arita M, Sato Y et al 1997 Affinity for α-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Lett 409:105-108
15. Jialal I, Devaraj S 2003 Antioxidants and atherosclerosis: don't throw out the baby with the bath water. Circulation 107:926-928
16. Jishage K-I, Tachibe T, Ito T et al 2005 Vitamin E is essential for mouse placentation but not for embryonic development itself. Biol Reprod 73:983-987
17. Lee IM, Cook NR, Gaziano JM et al 2005 Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA 294:56-65
18. Lonn E, Bosch J, Yusuf S et al 2005 Effects of long-term vitamin E supplementation on cardiovascular events and cancer. A randomized controlled trial. JAMA 293:1338-1347
19. Mattill HA 1927 The oxidative destruction of vitamins A and E and the protective action of certain vegetable oils. J Am Med Assoc 89:1505-1508
20. Meagher EA, Barry OP, Lawson JA, Rokach J, FitzGerald G 2001 Effects of vitamin E on lipid peroxidation in healthy persons. JAMA 285:1178-1182
21. Oram JF, Vaughan AM, Stocker R 2001 ATP-binding cassette transporter A1 mediates cellular secretion of α-tocopherol. J Biol Chem 276:39898-39902
22. Pham DQ, Plakogiannis R 2005a Vitamin E supplementation in cardiovascular disease and cancer prevention: Part 1. Ann Pharmacother 39:1870-1878
23. Pham DQ, Plakogiannis R 2005b Vitamin E supplementation in Alzheimer's disease, Parkinson's disease, tardive dyskinesia, and cataract: Part 2. Ann Pharmacother 39: 2065-2072
24. RDI 2000 Vitamin E. RDI Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. The National Academy of Sciences, p 186-283
25. Rigotti A, Miettinen HE, Krieger M 2003 The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues. Endocr Rev 24:357-387
26. Salonen RM, Nyyssönen K, Kaikkonen J et al 2003 Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation 107:947-953
27. Sokol RJ 1993 Vitamin E deficiency and neurological disorders. In: Packer L, Fuchs J (eds) Vitamin E in health and disease. Marcel Dekker, New York p 815-849
28. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL 1989 Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915-924
29. Stephens NG, Parsons A, Schofield PM et al 1996 Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347:781-786
30. Stocker R, Keaney JF Jr 2004 Role of oxidative modifications in atherosclerosis. Physiol Rev 84:1381-1478
31. Stocker R, O'Halloran RA 2004 Dealcoholized red wine decreases atherosclerosis in apolipoprotein E gene-deficient mice independently of inhibition of lipid peroxidation in the artery wall. Am J Clin Nutr 79:123-130
32. Suarna C, Wu BJ, Choy K et al 2006 Protective effect of vitamin E supplements on experimental atherosclerosis is modest and depends on pre-existing vitamin E deficiency. Free Radic Biol Med 41:722-730
33. Tappel AL, Zalkin H 1960 Inhibition of lipid peroxidation in microsomes by vitamin E. Nature 185:35
34. Tardif J-C, Côté G, Lespérance J et al 1997 Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. N Engl J Med 337:365-372
35. Terasawa Y, Ladha Z, Leonard SW et al 2000 Increased atherosclerosis in hyperlipidemic mice deficient in α-tocopherol transfer protein and vitamin E. Proc Natl Acad Sci USA 97:13830-13834
36. Witting PK, Pettersson K, Östlund-Lindqvist AM, Westerlund C, Wågberg M, Stocker R 1999a Dissociation of atherogenesis from aortic accumulation of lipid hydro(pero)xides in Watanabe heritable hyperlipidemic rabbits. J Clin Invest 104:213-220
37. Witting PK, Pettersson K, Östlund-Lindqvist AM, Westerlund C, Eriksson AW, Stocker R 1999b Inhibition by a co-antioxidant of aortic lipoprotein lipid peroxidation and atherosclerosis in apolipoprotein E and low density lipoprotein receptor gene double knockout mice. FASEB J 13:667-675
38. Witting PK, Pettersson K, Letters J, Stocker R 2000a Anti-atherogenic effect of coenzyme Q10 in apolipoprotein E gene knockout mice. Free Radic Biol Med 29:295-305
39. Witting PK, Pettersson K, Letters J, Stocker R 2000b Site-specific anti-atherogenic effect of probucol in apolipoprotein E deficient mice. Arterioscler Thromb Vasc Biol 20: e26-33
40. Wu BJ, Kathir K, Witting PK et al 2006 Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging. J Exp Med 203: 1117-1127
41. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P 2000 Vitamin E supplementation and cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators. N Engl J Med 342:154-160